Back to Search
Start Over
Restorative functions of Autologous Stem Leydig Cell transplantation in a Testosterone-deficient non-human primate model.
- Source :
-
Theranostics [Theranostics] 2020 Jul 09; Vol. 10 (19), pp. 8705-8720. Date of Electronic Publication: 2020 Jul 09 (Print Publication: 2020). - Publication Year :
- 2020
-
Abstract
- Rationale: Stem Leydig cells (SLCs) transplantation can restore testosterone production in rodent models and is thus a potential solution for treating testosterone deficiency (TD). However, it remains unknown whether these favorable effects will be reproduced in more clinically relevant large-animal models. Therefore, we assessed the feasibility, safety and efficacy of autologous SLCs transplantation in a testosterone-deficient non-human primate (NHP) model. Methods: Cynomolgus monkey SLCs (CM-SLCs) were isolated from testis biopsies of elderly (> 19 years) cynomolgus monkeys by flow cytometry. Autologous CM-SLCs were injected into the testicular interstitium of 7 monkeys. Another 4 monkeys were injected the same way with cynomolgus monkey dermal fibroblasts (CM-DFs) as controls. The animals were then examined for sex hormones, semen, body composition, grip strength, and exercise activity. Results: We first isolated CD271 <superscript>+</superscript> CM-SLCs which were confirmed to expand continuously and show potential to differentiate into testosterone-producing Leydig cells (LCs) in vitro . Compared with CM-DFs transplantation, engraftment of autologous CM-SLCs into elderly monkeys could significantly increase the serum testosterone level in a physiological pattern for 8 weeks, without any need for immunosuppression. Importantly, CM-SLCs transplantation recovered spermatogenesis and ameliorated TD-related symptoms, such as those related to body fat mass, lean mass, bone mineral density, strength and exercise capacity. Conclusion: For the first time, our short-term observations demonstrated that autologous SLCs can increase testosterone levels and ameliorate relevant TD symptoms in primate models. A larger cohort with long-term follow-up will be required to assess the translational potential of autologous SLCs for TD therapy.<br />Competing Interests: Competing Interests: The authors have declared that no competing interest exists.<br /> (© The author(s).)
- Subjects :
- Adipose Tissue
Animals
Bone Density
Cell Differentiation
Cell Proliferation
Cells, Cultured
Disease Models, Animal
Feasibility Studies
Humans
Leydig Cells metabolism
Macaca fascicularis
Male
Spermatogenesis
Transplantation, Autologous
Leydig Cells cytology
Stem Cell Transplantation methods
Testosterone blood
Testosterone deficiency
Subjects
Details
- Language :
- English
- ISSN :
- 1838-7640
- Volume :
- 10
- Issue :
- 19
- Database :
- MEDLINE
- Journal :
- Theranostics
- Publication Type :
- Academic Journal
- Accession number :
- 32754273
- Full Text :
- https://doi.org/10.7150/thno.46854